emcardioНеотложная кардиология и кардиоваскулярные рискиEmergency Cardiology and Cardiovascular Risks journal2616-633XБелорусский государственный медицинский университет10.51922/2616-633X.2022.6.1.1555emcardio-97Research ArticleКлинический случайТранскатетерная имплантация клапана легочной артерии после хирургической коррекции путей оттока правого желудочка: опыт одного центраTranscatheter pulmonary valve imlantation after surgical correction of right ventricular outflow tract: the experience of one centerЧерноглазП. Ф.CharnahlazP.

г. Минск

Minsk

КадочкинВ. О.KadochkinV.

г. Минск

Minsk

ЛинникЮ. И.LinnikY.

г. Минск

Minsk

ДроздовскийК. В.DrozdovskiK.

г. Минск

Minsk

ГУ «РНПЦ детской хирургии»Republican Centre of Pediatric Surgery2022270620256115551562Copyright © Черноглаз П.Ф., Кадочкин В.О., Линник Ю.И., Дроздовский К.В., 20252025Черноглаз П.Ф., Кадочкин В.О., Линник Ю.И., Дроздовский К.В.Charnahlaz P., Kadochkin V., Linnik Y., Drozdovski K.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://emcardio.bsmu.by/jour/article/view/97

Транскатетерная имплантация клапана легочной артерии (ТИКЛА) относительно новая методика, используемая для коррекции дисфункции выносящего отдела правого желудочка (ВОПЖ) после хирургического лечения врожденных пороков сердца. С момента внедрения в 2000 году Бонхоффером методики в клиническую практику тысячи таких вмешательств выполнены в мире. На данный момент в Республике Беларусь используются клапаны двух типов: клапан Melody TPVMedtronic и клапаны Edwards Sapien. Процедура ТИКЛА является безопасной и эффективной у большинства пациентов с дисфункцией легочных кондуитов и у части пациентов после трансаннулярной пластики ВОПЖ. Низкая частота осложнений и снижение числа повторных хирургических вмешательств в течение жизни пациента являются основными преимуществами данной методики. В данном обзоре представлен анализ литературы и обобщен опыт и результаты ТИКЛА у 24 пациентов в РНПЦ детской хирургии.

Transcatheter pulmonary valve implantation (TPVI) is a relatively new method of treating patients with right ventricular outflow tract (RVOT) dysfunction after surgical treatment of congenital heart defects. Since its introduction in 2000 by Bonhoeffer, more than ten thousand of such procedures have been performed worldwide. Currently two types of valves are available in the Republic of Belarus: Melody TPVMedtronic and Edwards Sapien. TPVI is safe and effective in the majority of patients with RVOT dysfunction and in some selected patients with patched RVOT. The low complication rate and the reduced number of open-chest re-interventions over a patient’s lifetime are among the main advantages of the procedure. The article presents a literature review, and summarizes the experience and results of TPVI performed on 24 patients in the Republican Centre of Pediatric Surgery.

транскатетерная имплантация клапана легочной артерииклапан легочной артерииврожденный порок сердцаtranscatheter pulmonary valve implantationpulmonary valvecongenital heart defectReferencesVerheugt C.L., Uiterwaal C., van der Velde E.T., Meijboom F.J., Pieper P.G., van Dijk A.P., Vliegen H.W., Grobbee D.E., Mulder B.J. Mortality in adult congenital heart disease. Eur Heart J, 2010, vol. 31, no. 10, pp. 1220–1229.Verheugt C.L., Uiterwaal C., van der Velde E.T., Meijboom F.J., Pieper P.G., van Dijk A.P., Vliegen H.W., Grobbee D.E., Mulder B.J. Mortality in adult congenital heart disease. Eur Heart J, 2010, vol. 31, no. 10, pp. 1220–1229.Giugno L., Faccini A., Carminati M. Percutaneous Pulmonary Valve Implantation. Korean Circ J, 2020, vol. 50, no. 4, pp. 302–316. doi.org/10.4070/kcj.2019.0291.Giugno L., Faccini A., Carminati M. Percutaneous Pulmonary Valve Implantation. Korean Circ J, 2020, vol. 50, no. 4, pp. 302–316. doi.org/10.4070/kcj.2019.0291.CHernoglaz P.F. Tetrada Fallo – «Staryj» porok v XXI veke – nereshennye voprosy etapnoj hirurgicheskoj korrekcii [Fallo’s Tetrada – “Old” Malformation in the XXI century – Unresolved Issues of Staged Surgical Correction]. Neotlozh. kardiologiya i kardiovaskulyar. riski, 2021, vol. 5, no. 1, pp. 1210–1216. (in Russian).CHernoglaz P.F. Tetrada Fallo – «Staryj» porok v XXI veke – nereshennye voprosy etapnoj hirurgicheskoj korrekcii [Fallo’s Tetrada – “Old” Malformation in the XXI century – Unresolved Issues of Staged Surgical Correction]. Neotlozh. kardiologiya i kardiovaskulyar. riski, 2021, vol. 5, no. 1, pp. 1210–1216. (in Russian).Homann M., Haehnel J.C., Mendler N., Paek S.U., Holper K., Meisner H., Lange R. Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur J Cardiothorac Surg, 2000, vol. 17, no. 6, pp. 624-630.Homann M., Haehnel J.C., Mendler N., Paek S.U., Holper K., Meisner H., Lange R. Reconstruction of the RVOT with valved biological conduits: 25 years experience with allografts and xenografts. Eur J Cardiothorac Surg, 2000, vol. 17, no. 6, pp. 624-630.Dearani J.A., Danielson G.K., Puga F.J., Schaff H.V., Warnes C.W., Driscoll D.J., Schleck C.D., Ilstrup D.M. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg, 2003, vol. 75, no. 2, pp. 399-410.Dearani J.A., Danielson G.K., Puga F.J., Schaff H.V., Warnes C.W., Driscoll D.J., Schleck C.D., Ilstrup D.M. Late follow-up of 1095 patients undergoing operation for complex congenital heart disease utilizing pulmonary ventricle to pulmonary artery conduits. Ann Thorac Surg, 2003, vol. 75, no. 2, pp. 399-410.Boethig D, Goerler H, Westhoff-Bleck M, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur J Cardiothorac Surg, 2007, vol. 32, pp. 133-141.Boethig D, Goerler H, Westhoff-Bleck M, et al. Evaluation of 188 consecutive homografts implanted in pulmonary position after 20 years. Eur J Cardiothorac Surg, 2007, vol. 32, pp. 133-141.Lindberg H.L., Saatvedt K., Seem E., Hoel T., Birkeland S. Single-center 50 years’ experience with surgical management of tetralogy of Fallot. Eur J Cardiothorac Surg, 2011, vol. 40, no. 3, pp. 538-542.Lindberg H.L., Saatvedt K., Seem E., Hoel T., Birkeland S. Single-center 50 years’ experience with surgical management of tetralogy of Fallot. Eur J Cardiothorac Surg, 2011, vol. 40, no. 3, pp. 538-542.Bouzas B., Kilner P.J., Gatzoulis M.A. Pulmonary regurgitation: not a benign lesion. Eur Heart J, 2005, vol. 26, no. 5, pp. 433-439.Bouzas B., Kilner P.J., Gatzoulis M.A. Pulmonary regurgitation: not a benign lesion. Eur Heart J, 2005, vol. 26, no. 5, pp. 433-439.Shin Y.R., Jung J.W., Kim N.K., Choi J.Y., Kim Y.J., Shin H.J., Park Y.H., Park H.K. Factors associated with progression of right ventricular enlargement and dysfunction after repair of tetralogy of Fallot based on serial cardiac magnetic resonance imaging. Eur J Cardiothoracic Surg, 2016, vol. 50, no. 3, pp. 464-469.Shin Y.R., Jung J.W., Kim N.K., Choi J.Y., Kim Y.J., Shin H.J., Park Y.H., Park H.K. Factors associated with progression of right ventricular enlargement and dysfunction after repair of tetralogy of Fallot based on serial cardiac magnetic resonance imaging. Eur J Cardiothoracic Surg, 2016, vol. 50, no. 3, pp. 464-469.Tretter J.T., Friedberg M.K., Wald R.M., McElhinney D.B. Defining and re-fining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: contributions from anatomical and functional imaging. Int J Cardiol, 2016, vol. 221, pp. 916-925.Tretter J.T., Friedberg M.K., Wald R.M., McElhinney D.B. Defining and re-fining indications for transcatheter pulmonary valve replacement in patients with repaired tetralogy of Fallot: contributions from anatomical and functional imaging. Int J Cardiol, 2016, vol. 221, pp. 916-925.Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot the quest continues. Circulation, 2013, vol. 128, no. 17, pp. 1855-1857.Geva T. Indications for pulmonary valve replacement in repaired tetralogy of fallot the quest continues. Circulation, 2013, vol. 128, no. 17, pp. 1855-1857.Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., Acar P., Le Bidois J., Sidi D. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet, 2000, vol. 356, no. 9239, pp. 1403-1405.Bonhoeffer P., Boudjemline Y., Saliba Z., Merckx J., Aggoun Y., Bonnet D., Acar P., Le Bidois J., Sidi D. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet, 2000, vol. 356, no. 9239, pp. 1403-1405.Medtronic Inc. Indications, Contraindications, Warnings, Precautions and Adverse Events: MelodyVR Transcatheter Pulmonary-Valve and EnsembleVR Transcatheter Delivery System. Medtronic, IncInternational Section, 2009 [electronic resource]. Available at: http://www.medtronic.com/intl/melody/melody_warn.html. (accessed 16.03.2022).Medtronic Inc. Indications, Contraindications, Warnings, Precautions and Adverse Events: MelodyVR Transcatheter Pulmonary-Valve and EnsembleVR Transcatheter Delivery System. Medtronic, IncInternational Section, 2009 [electronic resource]. Available at: http://www.medtronic.com/intl/melody/melody_warn.html. (accessed 16.03.2022).Garay F., Webb J., Hijazi Z.M. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv, 2006, vol. 67, pp. 659-662.Garay F., Webb J., Hijazi Z.M. Percutaneous replacement of pulmonary valve using the Edwards-Cribier percutaneous heart valve: first report in a human patient. Catheter Cardiovasc Interv, 2006, vol. 67, pp. 659-662.Demkow M., Biernacka E.K., Spiewak M., Kowalski M., Siudalska H., Wolski P., Sondergaard L., Miśko J., Hoffman P., Rużyłło W. Percutaneous pulmonary valve implantation preceded by routine presenting with a bare metal stent. Catheter Cardiovasc Interv, 2011, vol. 77, no. 3, pp. 381-389.Demkow M., Biernacka E.K., Spiewak M., Kowalski M., Siudalska H., Wolski P., Sondergaard L., Miśko J., Hoffman P., Rużyłło W. Percutaneous pulmonary valve implantation preceded by routine presenting with a bare metal stent. Catheter Cardiovasc Interv, 2011, vol. 77, no. 3, pp. 381-389.Cardoso R., Ansari M., Garcia D., Sandhu S., Brinster D., Piazza N. Prestenting for prevention of melody valve stent fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv, 2016, vol. 87, no. 3, pp. 534-539.Cardoso R., Ansari M., Garcia D., Sandhu S., Brinster D., Piazza N. Prestenting for prevention of melody valve stent fractures: a systematic review and meta-analysis. Catheter Cardiovasc Interv, 2016, vol. 87, no. 3, pp. 534-539.Baumgartner H., Bonhoeffer P., De Groot N.M.S., de Haan F., Deanfield J.E., Galie N., Gatzoulis M.A., Gohlke-Baerwolf C., Kaemmerer H., Kilner P., Meijboom F., Mulder B.J., Oechslin E., Oliver J.M., Serraf A., Szatmari A., Thaulow E., Vouhe P.R., Walma E. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J, 2010, vol. 31, no. 23, pp. 2915-2957.Baumgartner H., Bonhoeffer P., De Groot N.M.S., de Haan F., Deanfield J.E., Galie N., Gatzoulis M.A., Gohlke-Baerwolf C., Kaemmerer H., Kilner P., Meijboom F., Mulder B.J., Oechslin E., Oliver J.M., Serraf A., Szatmari A., Thaulow E., Vouhe P.R., Walma E. ESC Guidelines for the management of grown-up congenital heart disease (new version 2010). Eur Heart J, 2010, vol. 31, no. 23, pp. 2915-2957.Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P., Lung B., Kluin J., Lang I.M., Meijboom F., Moons P., Mulder B.J.M., Oechslin E., Roos-Hesselink J.W., Schwerzmann M., Sondergaard L., Zeppenfeld K. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J, 2021, vol. 42, no. 6, pp. 563-645. doi: 10.1093/eurheartj/ehaa554.Baumgartner H., De Backer J., Babu-Narayan S.V., Budts W., Chessa M., Diller G.P., Lung B., Kluin J., Lang I.M., Meijboom F., Moons P., Mulder B.J.M., Oechslin E., Roos-Hesselink J.W., Schwerzmann M., Sondergaard L., Zeppenfeld K. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J, 2021, vol. 42, no. 6, pp. 563-645. doi: 10.1093/eurheartj/ehaa554.Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M., Crumb S.R., Dearani J.A., Fuller S., Gurvitz M., Khairy P., Landzberg M.J., Saidi A., Valente A.M., Van Hare G.F. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines. Circulation, 2019, vol. 139, no. 14, pp. e637-e800.Stout K.K., Daniels C.J., Aboulhosn J.A., Bozkurt B., Broberg C.S., Colman J.M., Crumb S.R., Dearani J.A., Fuller S., Gurvitz M., Khairy P., Landzberg M.J., Saidi A., Valente A.M., Van Hare G.F. 2018 AHA/ACC guideline for the management of adults with congenital heart disease: executive summary: a report of the American College of Cardiology/ American Heart Association task force on clinical practice guidelines. Circulation, 2019, vol. 139, no. 14, pp. e637-e800.Silversides C.K., Marelli A., Beauchesne L., Dore A., Kiess M., Salehian O., Bradley T., Colman J., Connelly M., Harris L., Khairy P., Mital S., Niwa K., Oechslin E., Poirier N., Schwerzmann M., Taylor D., Vonder Muhll I., Baumgartner H., Benson L., Celermajer D., Greutmann M., Horlick E., Landzberg M., Meijboom F., Mulder B., Warnes C., Webb G., Therrien J. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol, 2010, vol. 26, no. 3, pp. 143-150.Silversides C.K., Marelli A., Beauchesne L., Dore A., Kiess M., Salehian O., Bradley T., Colman J., Connelly M., Harris L., Khairy P., Mital S., Niwa K., Oechslin E., Poirier N., Schwerzmann M., Taylor D., Vonder Muhll I., Baumgartner H., Benson L., Celermajer D., Greutmann M., Horlick E., Landzberg M., Meijboom F., Mulder B., Warnes C., Webb G., Therrien J. Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: executive summary. Can J Cardiol, 2010, vol. 26, no. 3, pp. 143-150.

The authors declare that there are no conflicts of interest present.